13F filer · CIK 1697748 ↗

ARK Invest

Cathie WoodChief Executive Officer and Chief Investment Officer

You are looking at Q3 2023. See the latest, Q2 2026 →

Reported value

$13.07B

−13% on the quarter before

Positions

226

13 new · 9 sold out

Top 10

47.5%

of the value

Est. gain

−$1.55B

on stocks held all quarter

Est. return

−11.0%

on those stocks since Q2 2023

Filed

Oct 18, 2023

On SEC EDGAR ↗

Positions as of Sep 30, 2023, from ARK Invest's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.

Portfolio at a glance

New
Added
Cut
Same
Options

Each tile is a position, sized by its share, colored by what the fund did with it since Q2 2023. Striped tiles are options.

202 others24%

Tesla7.8%UiPath6.2%Coinbase6.1%

Roku Inc5.6%

Zoom5.4%Block3.7%

Draftkings Inc3.3%

Exact Sciences Corp3.3%

Twilio3.2%

Shopify Inc2.9%

Teladoc Health Inc2.9%

Unity Software Inc2.8%

Roblox2.7%

Ginkgo Bioworks Holdings Inc2.5%

Crispr Therapeutics Ag2.5%

Robinhood2.5%

Intellia Therapeutics Inc2.4%

Pacific Biosciences Of Califor1.9%

Pagerduty Inc1.8%

Beam Therapeutics Inc1.6%

Veracyte Inc1.3%

Palantir1.2%Teradyne1.1%

Twist Bioscience Corp1.1%

202 others24%

Tesla7.8%UiPath6.2%Coinbase6.1%

Roku Inc5.6%

Zoom5.4%Block3.7%

Draftkings Inc3.3%

Exact Sciences Corp3.3%

Twilio3.2%

Shopify Inc2.9%

Teladoc Health Inc2.9%

Unity Software Inc2.8%

Roblox2.7%

Ginkgo Bioworks Holdings Inc2.5%

Crispr Therapeutics Ag2.5%

Robinhood2.5%

Intellia Therapeutics Inc2.4%

Pacific Biosciences Of Califor1.9%

Pagerduty Inc1.8%

Beam Therapeutics Inc1.6%

Veracyte Inc1.3%

Palantir1.2%Teradyne1.1%

Twist Bioscience Corp1.1%

Largest buys

Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Roblox~$76.9MAdded · 2.5% → 2.7%+2,655,333 shares
Archer Aviation Inc~$74.0MAdded · 0.2% → 0.9%+14,625,655 shares
Palantir~$41.3MAdded · 0.7% → 1.2%+2,580,638 shares
Pacific Biosciences Of Califor~$26.6MAdded · 2.3% → 1.9%+3,187,820 shares
Meta~$26.2MAdded · 0.4% → 0.7%+87,180 shares
Teradyne~$25.2MAdded · 0.9% → 1.1%+250,614 shares
Ginkgo Bioworks Holdings Inc~$22.5MAdded · 2.1% → 2.5%+12,442,658 shares
Iridium Communications Inc~$17.1MAdded · 0.6% → 0.7%+376,733 shares
Recursion Pharmaceuticals Inc~$16.4MAdded · 0.2% → 0.4%+2,138,081 shares
Spotify Technology Sa~$15.5MAdded · 0.0% → 0.1%+100,026 shares

Largest sells

Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.

Tesla~$191.4MCut · 8.4% → 7.8%−764,970 shares
Coinbase~$114.0MCut · 5.7% → 6.1%−1,518,317 shares
Roku Inc~$107.2MCut · 5.1% → 5.6%−1,518,479 shares
Shopify Inc~$104.8MCut · 3.8% → 2.9%−1,919,646 shares
Draftkings Inc~$101.1MCut · 3.2% → 3.3%−3,432,611 shares
Exact Sciences Corp~$59.6MCut · 4.4% → 3.3%−874,167 shares
Nvidia~$30.9MCut · 0.8% → 0.7%−70,939 shares
Zoom~$19.5MCut · 4.7% → 5.4%−279,393 shares
Schrödinger~$19.3MCut · 1.2% → 0.6%−681,452 shares
UiPath~$16.3MCut · 5.3% → 6.2%−954,511 shares

Holdings

As of Sep 30, 2023. Changes are in shares against Jun 30, 2023, so a price move alone never reads as a buy or a sale.

Positions, sorted by share of the portfolio
#	Holding		% prev	Value	Shares		Price	Prev price
1	TeslaCommon Stock · shares −16% · price −4.4%	7.8%	8.4%	$1.02B	4.1M	−16%	$250.22	$261.77	−4.4%	−$47.1M
2	UiPathCommon Stock · shares −2.0% · price +3.3%	6.2%	5.3%	$809.8M	47.3M	−2.0%	$17.11	$16.57	+3.3%	+$25.6M
3	CoinbaseCommon Stock · shares −13% · price +4.9%	6.1%	5.7%	$796.1M	10.6M	−13%	$75.08	$71.55	+4.9%	+$37.4M
4	Roku IncCommon Stock · shares −13% · price +10.4%	5.6%	5.1%	$736.9M	10.4M	−13%	$70.59	$63.96	+10.4%	+$69.2M
5	ZoomCommon Stock · shares −2.7% · price +3.0%	5.4%	4.7%	$712.2M	10.2M	−2.7%	$69.94	$67.88	+3.0%	+$21.0M
6	BlockCommon Stock · shares +1.5% · price −33.5%	3.7%	4.7%	$481.9M	10.9M	+1.5%	$44.26	$66.57	−33.5%	−$239.3M
7	Draftkings IncCommon Stock · shares −19% · price +10.8%	3.3%	3.2%	$430.6M	14.6M	−19%	$29.44	$26.57	+10.8%	+$42.0M
8	Exact Sciences CorpCommon Stock · shares −12% · price −27.3%	3.3%	4.4%	$428.5M	6.3M	−12%	$68.22	$93.90	−27.3%	−$161.3M
9	TwilioCommon Stock · shares +1.3% · price −8.0%	3.2%	3.0%	$417.4M	7.1M	+1.3%	$58.53	$63.62	−8.0%	−$35.8M
10	Shopify IncCommon Stock · shares −22% · price −15.5%	2.9%	3.8%	$379.5M	7.0M	−22%	$54.57	$64.60	−15.5%	−$69.8M
11	Teladoc Health IncCommon Stock · shares −0.2% · price −26.6%	2.9%	3.4%	$377.6M	20.3M	−0.2%	$18.59	$25.32	−26.6%	−$136.7M
12	Unity Software IncCommon Stock · shares −3.8% · price −27.7%	2.8%	3.4%	$360.3M	11.5M	−3.8%	$31.39	$43.42	−27.7%	−$138.1M
13	RobloxCommon Stock · shares +28% · price −28.1%	2.7%	2.5%	$346.8M	12.0M	+28%	$28.96	$40.30	−28.1%	−$105.7M
14	Ginkgo Bioworks Holdings IncCommon Stock · shares +7.3% · price −2.7%	2.5%	2.1%	$329.8M	182.2M	+7.3%	$1.81	$1.86	−2.7%	−$8.5M
15	Crispr Therapeutics AgCommon Stock · shares −2.4% · price −19.1%	2.5%	2.7%	$325.1M	7.2M	−2.4%	$45.39	$56.14	−19.1%	−$77.0M
16	RobinhoodCommon Stock · shares +2.9% · price −1.7%	2.5%	2.1%	$322.1M	32.8M	+2.9%	$9.81	$9.98	−1.7%	−$5.4M
17	Intellia Therapeutics IncCommon Stock · shares +4.4% · price −22.5%	2.4%	2.6%	$314.6M	9.9M	+4.4%	$31.62	$40.78	−22.5%	−$87.3M
18	Pacific Biosciences Of CaliforCommon Stock · shares +12% · price −37.2%	1.9%	2.3%	$249.0M	29.8M	+12%	$8.35	$13.30	−37.2%	−$131.8M
19	Pagerduty IncCommon Stock · shares +1.7% · price +0.0%	1.8%	1.5%	$237.4M	10.6M	+1.7%	$22.49	$22.48	+0.0%	+$103,797
20	Beam Therapeutics IncCommon Stock · shares +4.8% · price −24.7%	1.6%	1.8%	$211.3M	8.8M	+4.8%	$24.05	$31.93	−24.7%	−$66.1M
21	Veracyte IncCommon Stock · shares −3.0% · price −12.3%	1.3%	1.3%	$169.6M	7.6M	−3.0%	$22.33	$25.47	−12.3%	−$23.8M
22	PalantirCommon Stock · shares +38% · price +4.4%	1.2%	0.69%	$150.8M	9.4M	+38%	$16.00	$15.33	+4.4%	+$4.6M
23	TeradyneCommon Stock · shares +21% · price −9.8%	1.1%	0.86%	$142.9M	1.4M	+21%	$100.46	$111.33	−9.8%	−$12.7M
24	Twist Bioscience CorpCommon Stock · shares −2.5% · price −1.0%	1.1%	0.94%	$137.5M	6.8M	−2.5%	$20.26	$20.46	−1.0%	−$1.4M
25	10x Genomics IncCommon Stock · shares −3.9% · price −26.1%	0.94%	1.2%	$123.5M	3.0M	−3.9%	$41.25	$55.84	−26.1%	−$43.7M
	Total · 226 positions	100%		$13.07B						−$1.55B

The filing on SEC EDGAR ↗

Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.

What made money

From Q2 2023 to Q3 2023: 212 stocks held throughout, down $1.55B (−11.0%).

Roku Inc+$69.2M+10%
Draftkings Inc+$42.0M+11%
Coinbase+$37.4M+5%
UiPath+$25.6M+3%
Zoom+$21.0M+3%
Pacific Biosciences Of Califor−$131.8M−37%
Teladoc Health Inc−$136.7M−27%
Unity Software Inc−$138.1M−28%
Exact Sciences Corp−$161.3M−27%
Block−$239.3M−34%

Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.

Reported value by quarter

The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.

$60.00B$30.00B$0

Q4 201639 quartersQ2 2026

Every quarter's filing

Each quarter's 13F filing, newest first
Quarter	Filed	Reported value	Positions	Filing
Q2 2026	Aug 14, 2026	$15.40B+20%	191	SEC ↗
Q1 2026	May 12, 2026	$12.86B−15%	182	SEC ↗
Q4 2025	Feb 11, 2026	$15.07B−10%	196	SEC ↗
Q3 2025	Nov 12, 2025	$16.80B+23%	196	SEC ↗
Q2 2025	Jul 30, 2025	$13.64B+37%	191	SEC ↗
Q1 2025	May 7, 2025	$9.99B−17%	196	SEC ↗
Q4 2024	Feb 4, 2025	$12.01B+10%	183	SEC ↗
Q3 2024	Oct 31, 2024	$10.93B−3%	194	SEC ↗
Q2 2024	Jul 26, 2024	$11.27B−22%	190	SEC ↗
Q1 2024	Apr 18, 2024	$14.44B−14%	230	SEC ↗
Q4 2023	Jan 17, 2024	$16.89B+29%	223	SEC ↗
Q3 2023	Oct 18, 2023	$13.07B−13%	226	SEC ↗
Q2 2023	Jul 10, 2023	$15.10B+4%	222	SEC ↗
Q1 2023	Apr 17, 2023	$14.55B+26%	221	SEC ↗
Q4 2022	Jan 24, 2023	$11.54B−20%	232	SEC ↗
Q3 2022	Oct 17, 2022	$14.35B−15%	250	SEC ↗
Q2 2022	Jul 11, 2022	$16.91B−29%	354	SEC ↗
Q1 2022	Apr 18, 2022	$23.96B−28%	353	SEC ↗
Q4 2021	Jan 28, 2022	$33.08B−21%	368	SEC ↗
Q3 2021	Nov 12, 2021	$41.64B−23%	300	SEC ↗
Q2 2021	Aug 5, 2021	$53.74B+7%	285	SEC ↗
Q1 2021	May 13, 2021	$50.34B+34%	290	SEC ↗
Q4 2020	Feb 12, 2021	$37.59B+123%	244	SEC ↗
Q3 2020	Oct 30, 2020	$16.86B+81%	223	SEC ↗
Q2 2020	Aug 11, 2020	$9.30B+132%	213	SEC ↗
Q1 2020	May 14, 2020	$4.01B+1%	207	SEC ↗
Q4 2019	Jan 31, 2020	$3.96B−13%	218	SEC ↗
Q3 2019	Nov 12, 2019	$4.58B+15%	224	SEC ↗
Q2 2019	Jul 30, 2019	$3.97B+13%	229	SEC ↗
Q1 2019	May 13, 2019	$3.50B+42%	196	SEC ↗
Q4 2018	Feb 11, 2019 (amended)	$2.46B−26%	194	SEC ↗
Q3 2018	Nov 7, 2018	$3.31B+21%	202	SEC ↗
Q2 2018	Aug 7, 2018	$2.73B+36%	200	SEC ↗
Q1 2018	May 14, 2018	$2.01B+60%	199	SEC ↗
Q4 2017	Feb 12, 2018	$1.26B+53%	200	SEC ↗
Q3 2017	Nov 9, 2017	$819.3M+60%	145	SEC ↗
Q2 2017	Aug 11, 2017	$513.6M+48%	109	SEC ↗
Q1 2017	May 15, 2017	$346.9M+26%	104	SEC ↗
Q4 2016	Feb 13, 2017	$274.9M	102	SEC ↗